SavedAdd your journal

Journals / MN Kardiyoloji / 2006 / Cilt: 13 - Sayı: 4

A case with acute myocardial infarction-coronary thrombus developed after cisplatin application in non-hodgkin lymphoma treatment

Non - hodgkin lenfoma tedavisinde sisplatin kullanımı sonrası gelişen akut miyokard infarktüsü - koroner trombüs olgusu

TURGUT KARABAĞ
Ekrem YETER
Kurtuluş ÖZDEMİR
Fatih KOÇ
Pages
264–266
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, a case with non-Hodgkin lymphoma in which recurrence developed despite 6 times different antineoplastic agents usage, MI occured because of coronary thrombus after cisplatin is applied in addition to MOPP protocole treatment (meclorethamine, vincristin, procarbazine, prednisone) in the last cure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It is known that some cardiovascular complications such as myocardial infarction (MI) occur after use of antineoplastic agents.
📊
Key Findings & Data:It is known that some cardiovascular complications such as myocardial infarction (MI) occur after use of antineoplastic agents.
💡
Conclusion & Impact:In this paper, a case with non-Hodgkin lymphoma in which recurrence developed despite 6 times different antineoplastic agents usage, MI occured because of coronary thrombus after cisplatin is applied in addition to MOPP protocole treatment (meclorethamine, vincristin, procarbazine, prednisone) in the last cure.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antineoplastik birleşik kemoterapi protokolleri · Miyokard enfarktüsü · Erkek

Abstract

It is known that some cardiovascular complications such as myocardial infarction (MI) occur after use of antineoplastic agents. In this paper, a case with non-Hodgkin lymphoma in which recurrence developed despite 6 times different antineoplastic agents usage, MI occured because of coronary thrombus after cisplatin is applied in addition to MOPP protocole treatment (meclorethamine, vincristin, procarbazine, prednisone) in the last cure.

Özet

Antineoplastik ajanların kullanımı sonrası miyokard infarktüsü (Mİ) gibi kardiyovasküler komplikasyonlar geliştiği bilinmektedir. Bu yazıda non-Hodgkin lenfoma nedeniyle daha önce 6 kez farklı antineoplastik ajanlar kullanılmasına rağmen rekürrensler gelişen ve son kürde MOPP protokolü (mekloretamin, vincristin, prokarbazin, prednizon) tedavisine ilave olarak sisplatin verildikten sonra koroner trombüs sonucu Mİ gelişen bir olgu sunulmuş ve tartışılmıştır.

🔖

Cite This Article

KARABAĞ, T., YETER, E., ÖZDEMİR, K., KOÇ, F. (2006). A case with acute myocardial infarction-coronary thrombus developed after cisplatin application in non-hodgkin lymphoma treatment. MN Kardiyoloji, Cilt: 13 - Sayı: 4, 264–266. https://ajindex.com/articles/297529

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Simbre VC, Duffy SA, Dadlani GH, Miller TL, Lipshultz SE. Cardiotoxicity of cancer chemotherapy: implications for children. Paediatr Drugs 2005; 7:187-202.
  2. Doll DC, Yarbro JW. Vascular toxicity associated with antineoplastic agents. Semin Oncol 1992; 19:580-96.
  3. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 2000; 22:263-302.
  4. Betriu A, Castaner A, Sanz GA, et al. Angiographic finding 1 month after myocardial infarction: A prospective study. Circulation 1982; 65:1099-1105.
  5. Eliot RS, Baroldi G, Leone A. Necropsy studies in myocardial infarction with minimal or no coronary luminal reduction due to atherosclerosis. Circulation 1974; 49:1127-31.
  6. Kurum T, Dogutan H. Nonatherosclerotic causes of coronary artery disease. Anadolu Kardiyol Derg 2003; 3:348-352.
  7. Stefenelli T, Kuzmits R, Ulrich W, Glogar D. Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastin and bleomycin for testicular cancer. Eur Heart J 1988; 9:552-6.
  8. Samuel ML, Lanzotti ML, Holoye PY, Boyle LE, Smith TL, Johnson DE. Combination chemotherapy in germinal cell tumors. Cancer Treat Rev 1976; 3:185-204.
  9. Icli F, Karaoguz H, Dincol D, et al. Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 1993; 72:587-93.
  10. Lajer H, Daogaard G. Cisplatin and hypomagnesemia. Cancer Treat Rev 1999; 25:47-58.
  11. Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980; 208:198-200.
  12. Licciardelo JT, Moake JL, Rudy CK, Karp DD, Homg WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42:296-300.
  13. Togna Gl, Togna AR, Franconi M, Caprino L. Cisplatin triggers platelet activation. Thromb Res 2000; 99:503-9.
  14. Ozeren A, Aydın M, Özkökeli M, Unalacak M, Bilge M. Treatment of intracoronary thrombus using tirofiban in a patient with normal coronary arteries. Jpn Heart J 2004; 45:343-6.